Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by husk16on Oct 06, 2013 1:39am
258 Views
Post# 21794412

Very Good AGM Webcast

Very Good AGM WebcastFinally some new stuff to talk about. Was sick of scrolling through posts about that guy flogging his blog and the Post-Hoc discussion over and over. RVX 208 Can and will go forward Low HDL patients on a statin is the focus results in 1/4 time and 1/4 dose lucky did a study with both statins (originally only Lipitor) Trial vs baseline not placebo Main question, ARE YOU SAVING LIVES?????? Increases stable plaque vs vulnerable plaque Interest level as high in Alzheimer's vs Cardiovascular within the last month Bottom line here is Don has to strike a deal. So discuss back and forth all you want. That is the only thing that matters now.
Bullboard Posts